SCHEMBL510929

SCHEMBL510929

O=C=Nc1ccc(Cc2ccccc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.83
TSHR P16473 1/20 0.83
CYP1A2 P05177 1/20 0.59
SLC22A2 O15244 1/20 0.50
CALM1 P0DP23 1/20 0.50
CYP2C9 P11712 1/20 0.46
PLA2G10 O15496 1/20 0.42
PLA2G2A P14555 1/20 0.42
LMNA P02545 1/20 0.42
LTA4H P09960 1/20 0.41
IDH1 O75874 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
PPARG P37231 3/20 0.39
PPARA Q07869 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylmethane SCHEMBL4537622 1.00 CYP3A4 (0.83) CYP3A4TSHRCYP1A2SLC22A2CALM1
Diphenylmethane SCHEMBL28882075 0.92 CYP3A4 (0.70) CYP3A4TSHRCYP1A2SLC22A2CALM1
SCHEMBL19943 0.91 CYP3A4 (1.00) CYP3A4TSHRCYP1A2SLC22A2CALM1
SCHEMBL12852256 0.91 CYP3A4 (1.00) CYP3A4TSHRCYP1A2SLC22A2CALM1
SCHEMBL2044965 0.91 CYP3A4 (1.00) CYP3A4TSHRCYP1A2SLC22A2CALM1
SCHEMBL1396496 0.91 CYP3A4 (1.00) CYP3A4TSHRCYP1A2SLC22A2CALM1
SCHEMBL30634516 0.89 CYP3A4 (0.95) CYP3A4TSHRCYP1A2SLC22A2CALM1
Water SCHEMBL8522858 0.89 CYP3A4 (0.95) CYP3A4TSHRCYP1A2SLC22A2CALM1
Ammonia Solution, Strong SCHEMBL3504367 0.89 CYP3A4 (0.95) CYP3A4TSHRCYP1A2SLC22A2CALM1
SCHEMBL13869615 0.88 CYP3A4 (0.77) CYP3A4TSHRCYP1A2SLC22A2CALM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693535-A Powder coating composition 阿科玛法国 2024-03-12 CN claimed
CN-1256359-C Monomer-free reactive polyurethane adhesion promoters HENKEL KGAA (DE) 2006-05-17 CN claimed
CN-1402742-A Adhesion promoters for monomer-free reactive polyurethanes HENKEL KGAA (DE) 2003-03-12 CN claimed
WO-2000043431-A1 PLASTICIZED COMPOSITION ACCUFLEX CORPORATION (US) 2000-07-27 WO claimed
US-4208399-A Tolyl isocyanate test antigens, methods for their preparation and use in detecting diisocyanates and antibodies to diisocyanates THE UNIVERSITY OF PITTSBURGH (US) 1980-06-17 US claimed
US-12590180-B2 Olefinic compositions comprising hydrocarbon resins ExxonMobil Product Solutions Company (US) 2026-03-31 US disclosed
EP-4713378-A1 ESTERIFIED ETHANOLAMINES FOR PREPARING ISOCYANURATE POLYMERS Covestro Deutschland AG (DE) 2026-03-25 EP disclosed
US-20250136744-A1 HYBRID OLEFINIC COMPOSITIONS COMPRISING RESIN COMPOSITIONS POLYMERIZABLE BY ADDITION OR CONDENSATION POLYMERIZATION REACTIONS ExxonMobil Product Solutions Company 2025-05-01 US disclosed
US-12247134-B2 Coating compositions MATERIA, INC. (US) 2025-03-11 US disclosed
EP-3774961-B1 ADDUCTS OF AMINE CATALYSTS FOR PRODUCING ISOCYANURATE POLYMERS COVESTRO DEUTSCHLAND AG (DE) 2025-01-15 EP disclosed
WO-2024236000-A1 ESTERIFIED ETHANOLAMINES FOR PREPARING ISOCYANURATE POLYMERS COVESTRO DEUTSCHLAND AG (DE) 2024-11-21 WO disclosed
EP-4464727-A1 ESTERIFIED ETHANOLAMINES FOR THE PREPARATION OF ISOCYANURATE POLYMERS Covestro Deutschland AG (DE) 2024-11-20 EP disclosed
WO-2003087045-A1 NOVEL METHOXYBENZAMIDE COMPOUNDS FOR USE IN MCH RECEPTOR RELATED DISORDERS 7TM PHARMA A/S (DK) 2003-10-23 WO disclosed
WO-2003087046-A1 NOVEL AMINOTETRALINE COMPOUNDS FOR USE IN MCH RECEPTOR RELATED DISORDERS 7TM PHARMA A/S (DK) 2003-10-23 WO disclosed
CN-1439506-A Water polyurethane elastic thin-wall products preparation UNIV SICHUAN (CN) 2003-09-03 CN disclosed
CN-1402742-A Adhesion promoters for monomer-free reactive polyurethanes HENKEL KGAA (DE) 2003-03-12 CN disclosed
WO-2003015910-A1 MICROCAPSULE DISPERSION BASF AKTIENGESELLSCHAFT (DE) 2003-02-27 WO disclosed
US-4383984-A Tolyl isocyanate and toluene diisocyanate test antigens, methods for their preparation and use in detecting diisocyanates and antibodies to diisocyanates UNIVERSITY OF PITTSBURGH (US) 1983-05-17 US disclosed
US-4088766-A PRODUCTION OF PROSTAGLANDINS IN MAMMALS THE UPJOHN COMPANY (US) 1978-05-09 US disclosed
US-4001256-A PROSTAGLANDIN PRODUCTION IN MAMMALS THE UPJOHN COMPANY (US) 1977-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590180-B2 Olefinic compositions comprising hydrocarbon resins RAD51, COG2, HRH2 CYP3A4 1941/4885TSHR 3166/4885CYP1A2 869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.